Hyoscine-N-Butyl Bromide Market Competition Tracking- Key Market Insights 2018-2027

1
Hyoscine-N-Butyl Bromide Market Forecast, Trend
Analysis Competition Tracking- Global Market
Insights 2018-2027

• Chemical Materials
• 17O Pages
• Published Mar 2019

2
Market Snapshot
3
Description

• Hyoscine-N-Butyl Bromide used to treat abdominal
  pain and spasms is available in both oral and
  injectable form. However, with increasing sales
  of Hyoscine-N-Butyl Bromide under the brandname
  Buscopan which is an oral medication, the
  application of Hyoscine-N-Butyl Bromide in oral
  form is gaining traction. Moreover, with a range
  of benefits on oral administration of
  Hyoscine-N-Butyl Bromide, it is being used on a
  large scale. Upon oral administration, it binds
  and blocks muscarinic receptors, thereby,
  providing anti-spasmodic effect in the uterine,
  gastrointestinal, and urinary tracts. 
• The report on the Hyoscine-N-Butyl Bromide market
  serves as an authentic dataset for readers and
  players to plan business strategies in order to
  stay competitive in the Hyoscine-N-Butyl Bromide
  market.   

4
Hyoscine-N-Butyl Bromide Market- Key Insights

• Worldwide sales of Hyoscine-N-Butyl Bromide
  recorded a steady growth by registering 4.0 CAGR
  between 2013 and 2017. However, the market is
  likely to witness significant growth in the
  coming years owing to its wide application in
  treating various conditions and acting as muscle
  relaxant.
• The Hyoscine-N-Butyl Bromide market was valued at
  over US 50 million in 2018 and is projected to
  register Y-O-Y growth of 4.3 in 2019.
• Europe is expected to be the largest region in
  the Hyoscine-N-Butyl Bromide market during the
  forecast period and account for an estimated
  34.6 share by 2019 end.

5
Assessment of Competitive Landscape

• Boehringer Ingelheim has filed for the regulatory
  approval of Nintedanib for patients with systemic
  sclerosis associated interstitial lung disease
  with the EMA and FDA. Recently, Boehringer also
  entered into a research collaboration with GNA
  Biosolutions to develop emergency veterinary
  diagnostics, including rapid diagnostic test for
  African swine fever that can be used on the
  portable molecular diagnostic platform by GNA.
• The FDA has approved Dicyclomine HCl Injection,
  the generic version of Bentyl Injection by
  Aptalis Pharma. Dicyclomine HCl is an
  anti-spasmodic and anti-cholinergic agent that
  helps to relieve smooth muscle spasms in the
  gastrointestinal tract. The injection is supplied
  as 20mg/2ml.

6
Table of Contents

• 1. Global Hyoscine-N-Butyl Bromide Market -
  Executive Summary
• 2. Global Hyoscine-N-Butyl Bromide Market
  Overview     2.1. Introduction           
  2.1.1. Global Hyoscine-N-Butyl Bromide Market
  Taxonomy            2.1.2. Global
  Hyoscine-N-Butyl Bromide Market Definition   
   2.2. Global Hyoscine-N-Butyl Bromide Market Size
  (US Mn) and Forecast, 2013-2027           
  2.2.1. Global Hyoscine-N-Butyl Bromide Market
  Y-o-Y Growth     2.3. Global Hyoscine-N-Butyl
  Bromide Market Dynamics     2.4. Supply Chain 
     2.5. Cost Structure     2.6. Pricing
  Analysis      2.7. Raw Material Sourcing
  Strategy and Analysis     2.8. Service Provider
  List     2.9. Key Participants Market Presence
  (Intensity Map) By Region

7

• 3. Global Hyoscine-N-Butyl Bromide Market
  Analysis and Forecast 2013-2027      3.1. Global
  Hyoscine-N-Butyl Bromide Market Size and Forecast
  By Application, 2013-2027            3.1.1. Oral
  Market Size and Forecast, 2013-2027             
         3.1.1.1. Revenue (US Mn) Comparison, By
  Region                     3.1.1.2. Market Share
  Comparison, By Region                   
   3.1.1.3. Y-o-Y growth Comparison, By Region   
          3.1.2. Injectables Market Size and
  Forecast, 2013-2027                     3.1.2.1.
  Revenue (US Mn) Comparison, By Region         
             3.1.2.2. Market Share Comparison, By
  Region                     3.1.2.3. Y-o-Y growth
  Comparison, By Region
• 4. North America Hyoscine-N-Butyl Bromide Market
  Size and Forecast, 2013-2027     4.1. Revenue
  (US Mn) Comparison, By Country      4.2.
  Revenue (US Mn) Comparison, By Application 

8

• Scope
• The scope of Fact.MRs report is to analyze the
  Hyoscine-N-Butyl Bromide market for the forecast
  period 2018-2027 and provide readers an unbiased
  and accurate analysis. Hyoscine-N-Butyl Bromide
  manufacturers, stakeholders, and suppliers
  involved in the Hyoscine-N-Butyl Bromide market
  can benefit from the analysis offered in this
  report. This report offers a comprehensive
  analysis, which can be of interest to incumbent
  players and new entrants looking to enter the
  Hyoscine-N-Butyl Bromide market.
• Summary
• The report commences with a brief information of
  the Hyoscine-N-Butyl Bromide market. This
  executive summary sets the tone for the rest of
  the report, providing users the scope of the
  report. The executive summary includes important
  facts and statistics on the Hyoscine-N-Butyl
  Bromide market.

Request Free Sample Report
9
Get In Touch

• Want Tailor-made Report?
• Enquire at sales_at_factmr.com Now!
• Suite 9884 27 Upper Pembroke Street,
  Dublin 2, Ireland
• Toll Free 353-1-6111-593Email
  sales_at_factmr.comWebsite https//www.factmr.com/